Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2363017 Target Snapshot

Voltage-gated inwardly rectifying potassium channel KCNH3 · SINGLE PROTEIN · Homo sapiens

111Compounds
5Assays
0Approved Drugs
70.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt Q9ULD8. Use UniProt Q9ULD8 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q9ULD8 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Voltage-gated inwardly rectifying potassium channel KCNH3 as ChEMBL target CHEMBL2363017, mapped to UniProt Q9ULD8. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Voltage-gated inwardly rectifying potassium channel KCNH3
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL2363017
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
Q9ULD8
Voltage-gated inwardly rectifying potassium channel KCNH3
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Voltage-gated inwardly rectifying potassium channel KCNH3 is the right protein anchor across sources, using UniProt Q9ULD8 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelVoltage-gated inwardly rectifying potassium channel KCNH3
UniProt AccessionQ9ULD8
Component TypeProtein
Sequence Length1083 aa

Voltage-gated inwardly rectifying potassium channel KCNH3

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Voltage-gated inwardly rectifying potassium channel KCNH3, mapped to UniProt Q9ULD8. Sequence length is 1083 aa.

Mapped IDQ9ULD8
Review nameVoltage-gated inwardly rectifying potassium channel KCNH3
OrganismHomo sapiens
Assay Mix

Activity Type Distribution

IC5070.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL3987187 7.33 IC50 47.0 Preclinical
CHEMBL3902034 7.28 IC50 52.0 Preclinical
CHEMBL3960526 7.24 IC50 58.0 Preclinical
CHEMBL3908982 7.19 IC50 65.0 Preclinical
CHEMBL3918973 7.14 IC50 73.0 Preclinical
CHEMBL3979641 7.11 IC50 77.0 Preclinical
CHEMBL3913727 7.1 IC50 79.0 Preclinical
CHEMBL3916475 7.08 IC50 84.0 Preclinical
CHEMBL3912592 7.07 IC50 85.0 Preclinical
CHEMBL3934480 7.07 IC50 85.0 Preclinical
Distribution

pChEMBL Value Distribution

4
5.0
7
5.5
24
6.0
22
6.5
12
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Assay Landscape

Assay Landscape

5
Total Assays
70
Tested Compounds
1
Assay Types
Binding — 5 assays, 70 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 4 69 6.5
single protein format 1 1 4.4

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine